Read PulmCCM with Scottie
Keep PulmCCM. Lose the inbox pileup.
Scottie reads the newsletters you choose, keeps the useful differences, and attaches every original link. PulmCCM stays in your reading life without becoming another email to manage.
An independent guide. Scottie isn't affiliated with, endorsed by, or sponsored by PulmCCM. The publication owns its name, writing, and subscription terms.
From Scottie · July 31, 2026
See PulmCCM in a Scottie brief
Scottie read PulmCCM for a reader with the priorities shown below. Start with the rundown, open the full brief, or check every issue behind it.
1source
2issues read
2stories included
2 of 2 PulmCCM issues included
What shaped this brief
Reader priorities
A pulmonary or critical-care clinician who wants practice-changing trials and guidelines translated for ICU decisions.
These are illustrative priorities, not a customer’s data.
Sources in this brief
- PulmCCMThe publication this guide is about
Scottie
Scottie example brief
July 31, 2026 · Executive brief
01 / The rundown
- FDA approval of cefepime-zidebactam gives intensivists a new tool against resistant Gram-negative sepsis when paired with rapid PCR diagnostics.
- Briefly leaked staphylococcal bacteremia guidelines signal imminent practice changes regarding antibiotic treatment durations for severe bloodstream infections.
Read the complete brief 2 stories · 2 action items
02 / The briefing
01 / main
FDA approves cefepime-zidebactam for resistant Gram-negative sepsis
The takeaway: The FDA approved cefepime-zidebactam to treat multidrug-resistant Gram-negative pathogens like Pseudomonas and carbapenem-resistant Enterobacterales. Integrating rapid PCR testing with hospital alerts can help clinicians switch patients to effective coverage hours faster.
Concrete details
- Zidebactam provides direct bactericidal activity in addition to inhibiting beta-lactamase enzymes when paired with cefepime.
- PCR panels detect major bacterial resistance genes within two hours of blood culture positivity.
Why it matters for this reader: For critical care physicians managing septic shock, fast identification of resistance mechanisms lets you target antimicrobial therapy long before classic cultures finalize.
Original sourcesPulmCCM
02 / main
Infectious disease society briefly posts new staph bacteremia guidelines
The takeaway: A leading infectious diseases society briefly released and withdrew updated guidance on Staphylococcus aureus bacteremia. The forthcoming recommendations aim to refine treatment duration, helping clinicians determine when four to six week antibiotic regimens can be safely reduced.
Concrete details
- Staphylococcus aureus harmlessly colonizes the skin or mucous membranes of approximately one-third of individuals.
- Standard conservative treatment for low-risk staphylococcal bloodstream infections currently mandates at least 14 days of antibiotics.
Why it matters for this reader: Understanding upcoming shifts in bacteremia management will help you tailor post-ICU antibiotic durations and reduce long-term catheter complications for recovering sepsis patients.
Original sourcesPulmCCM
Action items
- Evaluate ICU protocols to integrate rapid PCR resistance panels into EMR alerts for positive blood cultures.
- Watch for the finalized infectious disease society guidelines to update staph bacteremia duration protocols in your unit.
See every issue behind this brief
FDA approval of cefepime-zidebactam for multidrug-resistant infections
- Treating Resistant Infections in the ICU: We Can Do BetterPulmCCM · Included
New clinical management guidelines for Staphylococcus aureus bacteremia
- Staph aureus bacteremia: new guideline will change managementPulmCCM · Included
About PulmCCM
Should you add PulmCCM to Scottie?
Keep up with evidence that can change pulmonary and critical-care practice.[1][2][3]
Who it’s for
A pulmonary or critical-care clinician who wants practice-changing trials and guidelines translated for ICU decisions.[1][2]
What you’ll find in it
The issues linked below include “The Latest in Critical Care, 1/22/24 (Issue #26)”, “Treating Resistant Infections in the ICU: We Can Do Better”, and “Staph aureus bacteremia: new guideline will change management”. Open them to judge the publication in its own words.
How to read PulmCCM with Scottie
Add its public feed for publicly available issues. If you subscribe to paid issues, forward those emails to your private @scottie.fyi address. Scottie does not need access to your inbox.
For this brief, Scottie read 2 PulmCCM items and included 2. It didn't mix in other publications, so there was no overlap to combine.
Read three issues from PulmCCM
Read the publication in its own words. Scottie keeps these original links attached; it does not replace the writing.